EUKEDOS SPA (EUK.MI) Fundamental Analysis & Valuation

BIT:EUK • IT0004818297

0.645 EUR
-0.03 (-3.73%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This EUK.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

EUK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. While EUK is still in line with the averages on profitability rating, there are concerns on its financial health. EUK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. EUK.MI Profitability Analysis

1.1 Basic Checks

  • In the past year EUK has reported negative net income.
  • In the past year EUK had a positive cash flow from operations.
  • In multiple years EUK reported negative net income over the last 5 years.
  • Each year in the past 5 years EUK had a positive operating cash flow.
EUK.MI Yearly Net Income VS EBIT VS OCF VS FCFEUK.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • With a Return On Assets value of -0.65%, EUK is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
  • With a Return On Equity value of -3.97%, EUK is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 2.64%, EUK is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for EUK is below the industry average of 6.06%.
  • The last Return On Invested Capital (2.64%) for EUK is above the 3 year average (2.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.65%
ROE -3.97%
ROIC 2.64%
ROA(3y)0.12%
ROA(5y)-0.11%
ROE(3y)0.54%
ROE(5y)-0.64%
ROIC(3y)2.58%
ROIC(5y)2.22%
EUK.MI Yearly ROA, ROE, ROICEUK.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

  • The Operating Margin of EUK (9.80%) is better than 90.91% of its industry peers.
  • EUK's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 95.00%, EUK belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
  • EUK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.8%
PM (TTM) N/A
GM 95%
OM growth 3Y-2.47%
OM growth 5Y3.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.24%
EUK.MI Yearly Profit, Operating, Gross MarginsEUK.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. EUK.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EUK is destroying value.
  • Compared to 1 year ago, EUK has about the same amount of shares outstanding.
  • Compared to 5 years ago, EUK has about the same amount of shares outstanding.
  • EUK has a better debt/assets ratio than last year.
EUK.MI Yearly Shares OutstandingEUK.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
EUK.MI Yearly Total Debt VS Total AssetsEUK.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 0.28, we must say that EUK is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.28, EUK is doing worse than 75.76% of the companies in the same industry.
  • A Debt/Equity ratio of 2.94 is on the high side and indicates that EUK has dependencies on debt financing.
  • EUK's Debt to Equity ratio of 2.94 is on the low side compared to the rest of the industry. EUK is outperformed by 75.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.94
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACC0.55
WACC4.78%
EUK.MI Yearly LT Debt VS Equity VS FCFEUK.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • EUK has a Current Ratio of 0.32. This is a bad value and indicates that EUK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EUK's Current ratio of 0.32 is on the low side compared to the rest of the industry. EUK is outperformed by 75.76% of its industry peers.
  • EUK has a Quick Ratio of 0.32. This is a bad value and indicates that EUK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EUK has a worse Quick ratio (0.32) than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
EUK.MI Yearly Current Assets VS Current LiabilitesEUK.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. EUK.MI Growth Analysis

3.1 Past

  • EUK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -260.63%.
  • The Revenue has been growing slightly by 4.81% in the past year.
  • Measured over the past years, EUK shows a decrease in Revenue. The Revenue has been decreasing by -0.94% on average per year.
EPS 1Y (TTM)-260.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-475.86%
Revenue 1Y (TTM)4.81%
Revenue growth 3Y6.09%
Revenue growth 5Y-0.94%
Sales Q2Q%3.39%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EUK.MI Yearly Revenue VS EstimatesEUK.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EUK.MI Yearly EPS VS EstimatesEUK.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 0.01 0.02 0.03 0.04 0.05

More info and screens

Find the best growth stocksShow best growing peers

0

4. EUK.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EUK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EUK.MI Price Earnings VS Forward Price EarningsEUK.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as EUK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.55
EUK.MI Per share dataEUK.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EUK.MI Dividend Analysis

5.1 Amount

  • EUK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EUK.MI Fundamentals: All Metrics, Ratios and Statistics

EUKEDOS SPA

BIT:EUK (3/11/2026, 7:00:00 PM)

0.645

-0.03 (-3.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap14.67M
Revenue(TTM)51.30M
Net Income(TTM)-1.15M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF 2.52
P/B 0.5
P/tB 1.65
EV/EBITDA 9.55
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.26
OCFY39.61%
SpS2.26
BVpS1.28
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.65%
ROE -3.97%
ROCE 3.52%
ROIC 2.64%
ROICexc 2.69%
ROICexgc 3.14%
OM 9.8%
PM (TTM) N/A
GM 95%
FCFM N/A
ROA(3y)0.12%
ROA(5y)-0.11%
ROE(3y)0.54%
ROE(5y)-0.64%
ROIC(3y)2.58%
ROIC(5y)2.22%
ROICexc(3y)2.64%
ROICexc(5y)2.29%
ROICexgc(3y)3.08%
ROICexgc(5y)2.68%
ROCE(3y)3.43%
ROCE(5y)2.97%
ROICexgc growth 3Y-1.81%
ROICexgc growth 5Y0.32%
ROICexc growth 3Y-1.47%
ROICexc growth 5Y0.29%
OM growth 3Y-2.47%
OM growth 5Y3.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.24%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 2.94
Debt/FCF N/A
Debt/EBITDA 7.49
Cap/Depr 328.04%
Cap/Sales 40.87%
Interest Coverage 250
Cash Conversion 50.88%
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z 0.28
F-Score5
WACC4.78%
ROIC/WACC0.55
Cap/Depr(3y)160.89%
Cap/Depr(5y)115.09%
Cap/Sales(3y)22.9%
Cap/Sales(5y)16.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-260.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-475.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.81%
Revenue growth 3Y6.09%
Revenue growth 5Y-0.94%
Sales Q2Q%3.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.09%
EBIT growth 3Y3.47%
EBIT growth 5Y2.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-480.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.86%
OCF growth 3Y20.95%
OCF growth 5Y10.45%

EUKEDOS SPA / EUK.MI FAQ

Can you provide the ChartMill fundamental rating for EUKEDOS SPA?

ChartMill assigns a fundamental rating of 1 / 10 to EUK.MI.


What is the valuation status for EUK stock?

ChartMill assigns a valuation rating of 0 / 10 to EUKEDOS SPA (EUK.MI). This can be considered as Overvalued.


What is the profitability of EUK stock?

EUKEDOS SPA (EUK.MI) has a profitability rating of 4 / 10.


How financially healthy is EUKEDOS SPA?

The financial health rating of EUKEDOS SPA (EUK.MI) is 1 / 10.